OpenFilings

PharmaCyte Biotech, Inc.

Form8-K/A

Report Period2025-09-02

Date Filed2025-11-18

Time Filed16:05:32

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

8-K/A
CONSENT OF STEPHANO SLACK LLC, INDEPENDENT AUDITOR OF Q/C
CONSENT OF MORISON COGEN LLP, INDEPENDENT AUDITOR OF Q/C
Q/C AUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2024 AND 2023,
Q/C UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2025, A
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Filing on SEC Edgar